http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36413130

Outgoing Links

Predicate Object
contentType Posted Content
publicationName bioRxiv : the preprint server for biology
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7345bb2c17d7a7dcada8f2e6aa9df6ca
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3d81906c35de473047c1e44d86721bd2
bibliographicCitation Yang M, Hutchinson N, Yin J, Guan M, Wang Z, Chen P, Yang S, Crane JD, Zhang K, Li J. Engineered Bacillus subtilis as oral probiotics to target circulating lactic acid. bioRxiv. 2023 Dec 01;(). PMID: 38076834; PMCID: PMC10705430.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e67482814ba21073a75e33723697256
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_939a5325d4e4a5f4cd14a2bb91e41a44
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c35e72f8c2a8f5b784619cc5f05600e3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae9d56d09b7682800b8a68812b0db9fe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c4d843049efc95fb6fe04242f58b7fe2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_de0febf863dba93b6bf2a39a46059201
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff15369c205952e3c6de9eac9e28f95a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b24d713aa8d7f3121b891b14eb1c0ea
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db1e3f3e83bf459aa0dc1c378505495f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_391cb4c7a6dc31e38f8093868bd34c75
date 2023-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1101/2023.11.30.569300
https://pubmed.ncbi.nlm.nih.gov/38076834
https://pubmed.ncbi.nlm.nih.gov/PMC10705430
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title EngineeredBacillus subtilisas oral probiotics to target circulating lactic acid

Total number of triples: 23.